This company listing is no longer active
IVERIC bio Balance Sheet Health
Financial Health criteria checks 5/6
IVERIC bio has a total shareholder equity of $477.0M and total debt of $97.0M, which brings its debt-to-equity ratio to 20.3%. Its total assets and total liabilities are $613.4M and $136.4M respectively.
Key information
20.3%
Debt to equity ratio
US$96.99m
Debt
| Interest coverage ratio | n/a |
| Cash | US$599.92m |
| Equity | US$477.05m |
| Total liabilities | US$136.36m |
| Total assets | US$613.41m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: O2T's short term assets ($611.5M) exceed its short term liabilities ($39.4M).
Long Term Liabilities: O2T's short term assets ($611.5M) exceed its long term liabilities ($97.0M).
Debt to Equity History and Analysis
Debt Level: O2T has more cash than its total debt.
Reducing Debt: O2T's debt to equity ratio has reduced from 445.2% to 20.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: O2T has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if O2T has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.